SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evolent Health, Inc. – ‘10-Q’ for 6/30/17 – ‘EXCEL’

On:  Monday, 8/7/17, at 4:05pm ET   ·   For:  6/30/17   ·   Accession #:  1628908-17-44   ·   File #:  1-37415

Previous ‘10-Q’:  ‘10-Q’ on 5/10/17 for 3/31/17   ·   Next:  ‘10-Q’ on 11/9/17 for 9/30/17   ·   Latest:  ‘10-Q’ on 5/10/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/07/17  Evolent Health, Inc.              10-Q        6/30/17   80:9.7M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    908K 
 2: EX-10.1     Material Contract                                   HTML     45K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
13: R1          Document and Entity Information                     HTML     46K 
14: R2          Consolidated Balance Sheets (Unaudited)             HTML    117K 
15: R3          Consolidated Balance Sheets (Unaudited)             HTML     46K 
                (Parenthetical)                                                  
16: R4          Consolidated Statements of Operations (Unaudited)   HTML    108K 
17: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML    123K 
18: R6          Consolidated Statements of Changes in               HTML     95K 
                Shareholders? Equity (Deficit) (Unaudited)                       
19: R7          Organization                                        HTML     29K 
20: R8          Basis of Presentation, Summary of Significant       HTML     71K 
                Accounting Policies and Change in Accounting                     
                Principle                                                        
21: R9          Recently Issued Accounting Standards                HTML     46K 
22: R10         Transactions                                        HTML    275K 
23: R11         Investments                                         HTML     69K 
24: R12         Property and Equipment, Net                         HTML     45K 
25: R13         Goodwill and Intangible Assets, Net                 HTML    105K 
26: R14         Long-term Debt                                      HTML     47K 
27: R15         Commitments and Contingencies                       HTML     99K 
28: R16         Earnings (Loss) Per Common Share                    HTML     78K 
29: R17         Stock-based Compensation                            HTML     77K 
30: R18         Income Taxes                                        HTML     32K 
31: R19         Investments In and Advances to Affiliates           HTML     29K 
32: R20         Non-controlling Interests                           HTML     57K 
33: R21         Fair Value Measurement                              HTML    111K 
34: R22         Related Parties                                     HTML     27K 
35: R23         Basis of Presentation, Summary of Significant       HTML     78K 
                Accounting Policies and Change in Accounting                     
                Principle (Policies)                                             
36: R24         Basis of Presentation, Summary of Significant       HTML     57K 
                Accounting Policies and Change in Accounting                     
                Principle (Tables)                                               
37: R25         Transactions (Tables)                               HTML    205K 
38: R26         Investments (Tables)                                HTML     71K 
39: R27         Property and Equipment, Net (Tables)                HTML     40K 
40: R28         Goodwill and Intangible Assets, Net (Tables)        HTML     90K 
41: R29         Long-term Debt (Tables)                             HTML     36K 
42: R30         Commitments and Contingencies (Tables)              HTML     73K 
43: R31         Earnings (Loss) Per Common Share (Tables)           HTML     80K 
44: R32         Stock-based Compensation (Tables)                   HTML     75K 
45: R33         Non-controlling Interests (Tables)                  HTML     47K 
46: R34         Fair Value Measurement (Tables)                     HTML    141K 
47: R35         Organization (Details)                              HTML     39K 
48: R36         Basis of Presentation, Summary of Significant       HTML     73K 
                Accounting Policies and Change in Accounting                     
                Principle (Details)                                              
49: R37         Transactions - Aldera (Details)                     HTML    152K 
50: R38         Transactions - Valence Health (Details)             HTML    253K 
51: R39         Transactions - Passport (Details)                   HTML     68K 
52: R40         Transactions - Pro Forma Information (Details)      HTML     42K 
53: R41         Transactions - Secondary Offerings (Details)        HTML     65K 
54: R42         Transactions - Accordion Health, Inc. (Details)     HTML     37K 
55: R43         Transactions - Vestica (Details)                    HTML     36K 
56: R44         Investments - Investment Summary (Details)          HTML     39K 
57: R45         Investments - Contractual Maturity (Details)        HTML     27K 
58: R46         Investments - Unrealized Losses (Details)           HTML     32K 
59: R47         Property and Equipment, Net (Details)               HTML     50K 
60: R48         Goodwill and Intangible Assets, Net (Details)       HTML     74K 
61: R49         Goodwill and Intangible Assets, Net - Goodwill      HTML     35K 
                (Details)                                                        
62: R50         Long-term Debt (Details)                            HTML     60K 
63: R51         Long-term Debt - Convertible Senior Notes Carrying  HTML     37K 
                Value and Interest Expense (Details)                             
64: R52         Commitments and Contingencies - Additional          HTML     73K 
                Information (Details)                                            
65: R53         Commitments and Contingencies - Lease Abandonment   HTML     31K 
                Liability (Details)                                              
66: R54         Commitments and Contingencies - Concentration Risk  HTML     52K 
                (Details)                                                        
67: R55         Earnings (Loss) Per Common Share - Computation of   HTML     53K 
                Earnings per Share (Details)                                     
68: R56         Earnings (Loss) Per Common Share - Antidilutive     HTML     36K 
                Securities (Details)                                             
69: R57         Stock-based Compensation - Compensation Expense     HTML     41K 
                (Details)                                                        
70: R58         Stock-based Compensation - Awards Granted           HTML     31K 
                (Details)                                                        
71: R59         Income Taxes (Details)                              HTML     37K 
72: R60         Investments In and Advances to Affiliates           HTML     41K 
                (Details)                                                        
73: R61         Non-controlling Interests (Details)                 HTML     95K 
74: R62         Fair Value Measurement - Assets and Liabilities on  HTML     44K 
                Recurring Basis (Details)                                        
75: R63         Fair Value Measurement - Changes in Contingent      HTML     31K 
                Consideration (Details)                                          
76: R64         Fair Value Measurement - Valuation Techniques and   HTML     47K 
                Significant Unobservable Inputs (Details)                        
77: R65         Related Parties (Details)                           HTML     25K 
79: XML         IDEA XML File -- Filing Summary                      XML    141K 
78: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 7: EX-101.INS  XBRL Instance -- evh-20170630                        XML   2.94M 
 9: EX-101.CAL  XBRL Calculations -- evh-20170630_cal                XML    207K 
10: EX-101.DEF  XBRL Definitions -- evh-20170630_def                 XML    921K 
11: EX-101.LAB  XBRL Labels -- evh-20170630_lab                      XML   1.54M 
12: EX-101.PRE  XBRL Presentations -- evh-20170630_pre               XML   1.11M 
 8: EX-101.SCH  XBRL Schema -- evh-20170630                          XSD    156K 
80: ZIP         XBRL Zipped Folder -- 0001628908-17-000044-xbrl      Zip    263K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/24  Evolent Health, Inc.              10-K       12/31/23  144:17M
 2/24/23  Evolent Health, Inc.              10-K       12/31/22  148:19M
 2/24/22  Evolent Health, Inc.              10-K       12/31/21  154:19M
 2/26/21  Evolent Health, Inc.              10-K       12/31/20  152:19M
Top
Filing Submission 0001628908-17-000044   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:23:57.1pm ET